CrushSCI.com
165.3Average days
109.5Median days
62Fastest days
575Longest days
922025 publications

Paper Review Records

All Paper Review Records

24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

235 days

Epitranscriptomic Regulation of PIK3R2 by WTAP/YTHDF3 Axis Drives Nasopharyngeal Carcinoma Progression

Authors
Yilong Xu; Yanyu Xu; Yongqin Chen; Shaorong Lin; Yaxue Liu; Sihai Dai; Mingyan HongShow moreShow less
Affiliations
1. Department of Otorhinolaryngology Quanzhou Maternity and Children's Hospital Quanzhou City Fujian Province China; 2. Department of Otolaryngology‐Head and Neck Surgery Quanzhou Maternity and Children's Hospital Quanzhou City Fujian Province ChinaShow moreShow less
Source PDF DOI Publisher page
190 days

Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer

Authors
Xinxing Li; Xin Yang; Lin Zhu; Junyong Weng; Zezhi Shan; Zhiqian Hu; Ariela Samantha; Io Nam Wong; Xinxiang LiShow moreShow less
Affiliations
1. Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China; 2. Department of Oncology, Shanghai Medical College Fudan University Shanghai China; 3. Department of General Surgery, Tongji Hospital, School of Medicine Tongji University Shanghai China; 4. Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope, Biomedical Research Center Monrovia California USA; 5. Proteomics Division, Mochtar Riady Institute for Nanotechnology Universitas Pelita Harapan Tangerang Banten Indonesia; 6. Department of Biology Universitas Pelita Harapan Tangerang Banten Indonesia; 7. Faculty of Medicine, Macau University of Science and Technology Macau China; 8. AI Cross Disciplinary Research Institute, Macau University of Science and Technology Macau China; 9. Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine Macau University of Science and Technology Macau China; 10. Zhuhai MUST Science and Technology Research Institute/Macau University of Science and Technology Innovation Technology Research Institute Hengqin ChinaShow moreShow less
Source PDF DOI Publisher page
324 days

Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS ‐Induced Colitis via Mucus Barrier Protection

Authors
Marcela S. C. Brito; Anderson K. Taporosky; Katlin S. Rech; Lucas B. S. Santos; Marcelo B. Gois; Larissa F. N. de Souza; Rilton A. de Freitas; Carolina A. B. Azevedo; Carolina Mathias; Lucimara M. C. Cordeiro; Maria F. P. WernerShow moreShow less
Affiliations
1. Pharmacology Department Federal University of Paraná Curitiba Paraná Brazil; 2. Biochemistry and Molecular Biology Department Federal University of Paraná Curitiba Paraná Brazil; 3. Faculty of Health Sciences of the Federal University of Rondonópolis Rondonópolis Mato Grosso Brazil; 4. BioPol, Pharmacy Department Federal University of Paraná Curitiba Paraná Brazil; 5. Genetic Department Federal University of Paraná Curitiba Paraná BrazilShow moreShow less
Source PDF DOI Publisher page
151 days

KRIT1 Inhibits TGF ‐β/Smad‐Mediated Endothelial‐To‐Mesenchymal Transition in Pulmonary Arterial Hypertension

Authors
Debin Ma; Liang Shi; Congcong Li; Di Song; Lei LiuShow moreShow less
Affiliations
1. Department of Respiratory and Critical Care Medicine General Hospital of Northern Theater Command Shenyang ChinaShow moreShow less
Source PDF DOI Publisher page
103 days

Targeting RAB27A Enhances Pembrolizumab Sensitivity and Alleviates Immune Escape via Inactivation of the PI3K /Akt/ mTOR Pathway in Triple‐Negative Breast Cancer

Authors
Tong Sha; Jingjing Fan; Xiaoli Wang; Binlin MaShow moreShow less
Affiliations
1. Department of Breast Thyroid Surgery, Xinjiang Medical University Affiliated Tumor Hospital The Clinical Medical Research Center of Breast and Thyroid Tumors in Xinjiang Urumqi ChinaShow moreShow less
Source PDF DOI Publisher page
105 days

Mechanistic Study of SRSF1 ‐Mediated Inhibition of Treg Cell Function via the mTORC1 / ULK1 Signalling Axis Through Mitophagy in Asthma

Authors
Chunhua Ye; Yifu Chen; Qinjun Yi; Zhu Ming; Tuoyu Gan; Rong XiangShow moreShow less
Affiliations
1. Department of Emergency Changsha Hospital for Maternal & Child Health Care Changsha Hunan China; 2. Department of Urology The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University(Hunan Children's Hospital) Changsha Hunan China; 3. Department of Pediatrics Changsha Hospital for Maternal & Child Health Care Changsha Hunan ChinaShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY take to review a manuscript?

As of 2026-11-17, CrushSCI has 24 complete review records for CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. The fastest paper went from submission to acceptance in 62 days (18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway, received 2026-07-01, accepted 2026-09-01); the slowest took 575 days. The average is 165.3 days and the median is 109.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.